A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 120.00
GOOG 804.61
MSFT 62.53
BAC 22.05
FB 127.87

Recently Added

RCL 84.99
GFF 24.65
RUTH 17.25
LAD 101.67
SF 48.54

Gaining Speed

RCL 84.99
RUTH 17.25
GFF 24.65
CCL 53.09
KMX 66.47

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!